Ipomoea aquatica extract shows protective action against

thioacetamide-induced hepatotoxicity by Abdullah, M.A. et al.
Molecules 2012, 17, 6146-6155; doi:10.3390/molecules17056146 
 
molecules 
ISSN 1420-3049 
www.mdpi.com/journal/molecules 
Article 
Ipomoea aquatica Extract Shows Protective Action Against 
Thioacetamide-Induced Hepatotoxicity 
Salim Said Alkiyumi 1, Mahmood Ameen Abdullah 1,*, Ahmed Salim Alrashdi 1,  
Suzy Munir Salama 1, Siddig Ibrahim Abdelwahab 2 and A. Hamid A. Hadi 3 
1 Department of Molecular Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia 
2 Department of Pharmacy, University of Malaya, 50603 Kuala Lumpur, Malaysia 
3 Department of Chemistry, University of Malaya, 50603 Kuala Lumpur, Malaysia 
* Author to whom correspondence should be addressed; E-Mail: ammeen@um.edu.my;  
Tel.: +6-037-967-6604; Fax: +6-037-967-6600. 
Received: 1 April 2012; in revised form: 20 April 2012 / Accepted: 23 April 2012 /  
Published: 22 May 2012 
 
Abstract: In the Indian system of traditional medicine (Ayurveda) it is recommended to 
consume Ipomoea aquatica to mitigate disorders like jaundice. In this study, the protective 
effects of ethanol extract of I. aquatica against liver damage were evaluated in thioacetamide 
(TAA)-induced chronic hepatotoxicity in rats. There was no sign of toxicity in the acute 
toxicity study, in which Sprague-Dawley (SD) rats were orally fed with I. aquatica (250 and 
500 mg/kg) for two months along with administration of TAA (i.p injection 200 mg/kg three 
times a week for two months). The results showed that the treatment of I. aquatica 
significantly lowered the TAA-induced serum levels of hepatic enzyme markers (ALP, ALT, 
AST, protein, albumin, bilirubin and prothrombin time). The hepatic content of activities and 
expressions SOD and CAT that were reduced by TAA were brought back to control levels by 
the plant extract supplement. Meanwhile, the rise in MDA level in the TAA receiving groups 
also were significantly reduced by I. aquatica treatment. Histopathology of hepatic tissues by 
H&E and Masson trichrome stains displayed that I. aquatica has reduced the incidence of liver 
lesions, including hepatic cells cloudy swelling, infiltration, hepatic necrosis, and fibrous 
connective tissue proliferation induced by TAA in rats. Therefore, the results of this study 
show that the protective effect of I. aquatica in TAA-induced liver damage might be 
contributed to its modulation on detoxification enzymes and its antioxidant and free radical 
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scavenger effects. Moreover, it confirms a scientific basis for the traditional use of I. aquatica 
for the treatment of liver disorders. 
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1. Introduction 
Ipomoea aquatica, which belongs to the family Convolvulaceae is supposed to be originated in China 
and is usually consumed as a green leafy vegetable [1]. This plant is widely distributed all around the 
World, especially India, Malaysia, Indonesia, China, Hong Kong and some parts of USA [2]. This plant is 
grown as an aquatic plant which grows abundantly in marshy areas. Various parts of the I. aquatica plant 
are used medicinally in Southeastern Asia and reported to be useful for the treatment of high blood 
pressure [3], as an emetic in the treatment of opium and arsenic poisoning [4]. The dried juice has reported 
to be a purgative [4], while the leaves and stems possess cooling action. Moreover, it is also traditionally 
used in the treatment of nervous and general debility, piles, worm infections, leucoderma, leprosy, 
jaundice and liver complaints [2]. Very few studies have been done in this plant. This includes the 
inhibition of prostaglandin synthesis [5], eye diseases, constipation [6] and hypoglycaemic effects [7]. 
Phytochemical investigations of this plant have revealed the presence of carotenes such as β-carotene, 
cryptoxanthin, lutein, lutein epoxide, violoxanthin and neoxanthin [8], flavonoids such as mycertin, 
quercetin, luteolin and apigenin [9] and some alkaloids [10].  
Even though the liver is the most significant organ of our body for detoxification, disorders to this 
organ remain some of the most serious health problems [11]. Liver diseases such as hepatocellular 
carcinoma, viral and alcoholic hepatitis and non-alcoholic steatosis are the most common liver-associated 
and prevalent diseases in the World, which are closely associated with jaundice [12]. As modern medicine 
fails to cure these ailments completely and harmlessly, research on natural products has gained much 
attention in the drug discovery against diseases such as liver diseases [13]. Most of the time the research 
will be guided by some traditional practice or from undocumented treatment modalities [14,15]. In the 
Indian system of traditional medicine (Ayurveda) it is recommended to consume I. aquatica to mitigate 
disorders like jaundice [2]. The effectiveness of these plant products from traditional claims must be 
proved to help develop noval drugs acting against these disorders. Nevertheless, no literature was found 
on the hepatoprotective action of this plant. Keeping this in view, the present study was aimed to evaluate 
the hepatoprotective activity of I. aquatica on thioacetamide-induced liver damage in rats.  
2. Results and Discussion 
2.1. Biochemical Parameters of the Liver  
In acute toxicity studies, the extract was found to be safe up to 5 g/kg. No mortality or toxic symptoms 
were observed during the entire duration of the study. Many types of chemical agents have been employed 
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previously for the indication of hepatic damage. Thioacetamide (TAA), which has been used in the 
present study, is a well-established tool to induce hepatotoxicity in experimental animals models [16,17]. 
TAA is able to produce different grades of hepatic damage, including centrilobular necrosis [18], 
inflammation and suppression of anti-oxidant activity [19]. In the current study the hepatic damage 
occurred was assessed by measuring serum levels of specific liver enzymes such as ALP, ALT, AST and 
bilirubin. Even though these enzymes were found to be elevated in the TAA treated group of animals due 
to the leakage of the enzymes from liver as a result of tissue damage, the plant extract treatment was found 
to significantly (p < 0.001) restore the enzyme levels both at 250 and 500 mg/kg. These results were well 
compared with the standard drug, silymarin (Table 1). 
Table 1. The effects of I. aquatica extracts and silymarin on the biochemical parameters in 
serum of TAA intoxicated rats. 
Group 
ALP 
IU/L 
ALT 
IU/L 
AST 
IU/L 
Protein 
g/L 
Albumin 
g/L 
Bilirubin 
g/L 
Prothrombin 
time (PT) 
Control 
(N.S) 
76.23 ± 0.47 37.8 ± 0.23 60.9 ± 0.75 68.65 ± 0.44 25.8 ± 0.32 1.23 ± 0.06 0.85 ± 0.01 
TAA+N.S 234.1 ± 0.28 * 160.8 ± 0.4 * 221.63 ± 1.45 * 48.88 ± 0.33 * 8.68 ± 0.34 * 4.73 ± 0.40 * 1.67 ± 0.03 * 
TAA+ Silymarin 80.36 ± 0.65 ** 38.13 ± 0.35 ** 66.01 ± 0.27 ** 66.81 ± 0.54 ** 24.76 ± 0.53 ** 1.24 ± 0.03 ** 0.91 ± 0.01 ** 
TAA+  
I. aquatica 
250mg/kg 
87.76 ± 0.43 ** 83.83 ± 0.25 ** 89.33 ± 0.57 ** 63.03 ± 0.63 ** 19.68 ± 0.34 ** 2.42 ± 0.09 ** 1.13 ± 0.02 ** 
TAA+  
I. aquatica  
500 mg/kg 
77.8 ± 0.46 ** 39.85 ± 0.33 ** 63.73 ± 0.30 ** 67.61 ± 0.27 ** 24.93 ± 0.45 ** 1.25 ± 0.03 ** 0.90 ± 0.02 ** 
Data are expressed as mean ± SEM. Means among groups (n = 6 rats/group) show significant difference, * p < 0.001 vs. normal group,  
** p < 0.001 vs. cirrhosis group. 
In most instances, the serum bilirubin levels must be elevated in hepatic jaundice [20]. We have 
observed a similar trend in the elevation of serum billurubin level during TAA traement, and concurrent 
reduction with the plant extract. It is well known that following cellular damage the capacity to synthesize 
proteins is reduced, and as the extent of damage increases, the levels of these proteins in the plasma will 
tend to decrease [21]. A similar observation was seen in our studies, where the total protein and total 
albumin levels in the serum were markedly decreased, but as seen in the silymarin treated group, the plant 
extract also restored these levels of protein to normal signifying a return from the abnormal state to normal.  
2.2. SOD, CAT and MDA Contents in Liver Homogenates  
Biological systems have protective arrangements which defend them against the harmful effects of free 
radicals. This includes SOD and CAT [22]. In the liver tissues of the hepatotoxicity control group, the 
antioxidant activity of SOD and CAT were significantly (p < 0.001) reduced as compared with the normal 
animal group. In hepatotoxicity these enzymes are structurally and functionally weakened by the radicals, 
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resulting in liver damage [23]. Meanwhile, the treatment group with both low and high dose of plant 
extract succeed in reversing the enzyme levels back by protecting the tissues from attack by free radicals.  
Due to the involvement of several pathological conditions, recently much attention has been paid to 
free radical peroxidation (Table 2). Lipid peroxidation, which refers to the oxidative degradation of lipids, 
is a multifarious and natural harmful process [24]. MDA level increases in the tissue represent an indirect 
index of lipid peroxidation. The increase in liver TBARS indicates enhanced lipid peroxidation leading  
to tissue injury and failure of the anti-oxidant defense mechanisms to prevent the formation of excess  
free radicals [11]. In the present study, thioacetamide induced a rise in MDA level has was significantly  
(p < 0.001) reduced by the extract (Table 2). 
Table 2. SOD, CAT and MDA contents in liver homogenates after two months treatment. 
Group SOD U/mg protein 
CAT 
U/mg protein 
MDA 
U/mg protein 
Control (N.S) 18.03 ± 0.24 38.76 ± 0.32 1.19 ± 0.04 
TAA+N.S. 8.63 ± 0.32 * 18.73 ± 0.32 * 4.80 ± 0.06 * 
TAA+ Silymarin 14.68 ± 0.21 ** 37.13 ± 0.40 ** 1.7 ± 0.04 ** 
TAA+ I. aquatica 250 mg/kg  12.41 ± 0.27 ** 26.46 ± 0.64 ** 2.33 ± 0.09 ** 
TAA+ I. aquatica 500 mg/kg  14.56 ± 0.29 ** 37.95 ± 0.24 ** 1.40 ± 0.09 ** 
Data are expressed as mean ± SEM. Means among groups (n = 6 rats/group) show significant difference, 
* p < 0.001 vs. normal group, ** p < 0.001 vs. cirrhosis group, *** p < 0.05 vs. cirrhosis group. 
2.3. Histopathological Study of the Liver 
The overall liver morphological changes and fibrosis induced by TAA administration were 
demonstrated by qualitative histopathological examination. The normal control animals showed regular 
hepatocytes with well-preserved cytoplasm, prominent nucleus, nucleolus and central vein in the 
histological profile. There was no sign of inflammation, fatty change and necrosis in these animals  
(Figure 1A,a and 1B,a).  
In animals administered with thioacetamide alone, liver sections showed marked congested central 
veins, sinusoid and multifocal area of necrosis, fatty changes and inflammatory cell with granular swelling 
(Figure 1B). In addition, the MT stain clearly demonstrated that fiber extension and collagen accumulation 
(Figure 1C,b) was also present. A high degree of vacuolation followed by marked congested veins, 
multifocal area of necrosis, fatty changes and inflammatory cells are substantial structures in the histology 
of a damaged liver [25]. Whereas the histological architecture of liver sections of the rats treated with the 
plant extract showed more or less normal lobular pattern with a mild degree of fatty change, necrosis and 
lymphocyte infiltration almost comparable to the control and silymarin treated groups. The plant extract 
exposure greatly improved liver morphological changes, fibrosis and necrosis, which is clearly seen in 
both Figure 1ABC,e. and well compared with control and Silymarin treated group. 
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Figure 1. Effects of I. aquatica extract on thioacetamide induced liver damage in rats. (a) 
Control group, (b) animals treated with thioacetamide, (c) animals treated with thioacetamide 
and silymarin, (d) animals treated with thioacetamide and I. aquatica 250 mg/kg and (e) 
animals treated with thioacetamide and I. aquatica 500 mg/kg. (A) Gross morphology, (B) 
Hematoxylin/eosin stain, (C) Masson trichrome stain; magnification 20×. 
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3. Experimental  
3.1. Plant Material 
The plant material of I. aquatica was purchased from the Ethno Sdn Bhd. The plant was identified, and 
voucher specimen was kept in our laboratory for future reference. The plant material was cut into small 
pieces, which were first washed with tap water and then with distilled water. The plant was then air dried 
for 7 days, after which the dried leaves were ground into a fine powder using a grinder. 
3.2. Extraction Procedure 
The dried plant was powdered (approximately 100 g) and was extracted with 95% ethanol (900 mL) for 
72 hours at room temperature. The suspension was stirred from time to time to allow the powder to fully 
dissolve in the ethanol. The ethanol extract was then filtered through cheesecloth, followed by filter paper 
(Whatman No. 1) and evaporated under low pressure by using Buchi-type rotary evaporator to a 
percentage yield of crude-dried extract of 18.4% (w/w). 
3.3. Experimental Animals  
The study was carried out using male Sprague-Dawley rats (195–215 g) obtained from the Animal 
House Unit, Faculty of Medicine, University of Malaya, Malaysia. The chosen animals were housed in 
bottomed cages at 25 ± 3 °C temperature, 50–60% humidity, and under a 12Ԝ h light-dark cycle for a week 
before the experiment. The animals were maintained at standard housing conditions and free access to 
standard diet and water ad libitum during the experiment. The experiment was performed in accordance to 
the guideline of taking care of animals prepared by the National Academy of Sciences.  
3.4. Chemicals 
All chemicals used in the experiment were of analytical grade and purchased from Sigma-Aldrich. 
Thioacetamide (Sigma-Aldrich, St. Gallen, Switzerland) was used as an inducer of liver cirrhosis and was 
dissolved in sterile distilled water and injected intraperitoneally to the experimental rats in concentrations 
of 200 mg/kg body weight [26]. Silymarin (International Laboratory, South San Francisco, CA, USA) 
used as a standard drug in the experiment, was dissolved in distilled water and orally administered to rats 
in dosage of 50 mg/kg body weight [27]. 
3.5. Acute Toxicity Test 
The procedure for this animal study was reviewed and then approved by Animal Ethics Committee 
(Ethic No. PM/27/07/2010/MAA). The acute toxicity study was undertaken employing a total of  
36 Sprague-Dawley rats. Eighteen male and 18 female rats ranging between 7–8 weeks of age procured 
from the Animal House Unit, Faculty of Medicine, University of Malaya, Malaysia. The animals were 
divided into three groups with six rats each marked as vehicle (distilled water, 5 mL/Kg, 2 g/kg and 5 g/kg) of 
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prepared extract, respectively. Prior to dosing the rats were fasted overnight and after the dose for another 
four hours. Following the dose the rats were carefully watched for the development of any clinical or 
toxicological symptoms at 30 min and then 2, 4, 8, 24 and 48 h. On the 15th day all the rats were sacrificed and 
samples for biochemical and histological studies were collected and analyzed per standard methods [28]. 
3.6. Preparation of Doses 
Distilled water was used to dissolve the crude-dried ethanol extract before oral administration to 
experimental rats. Plain distilled water was used to dissolve the standard drug, silymarin (50 mg/kg). The 
doses were prepared fresh each day.  
3.7. Protocol for Hepatoprotective Study 
Thirty rats were randomly divided into five groups of six animals each. Group 1 (normal control) 
received intraperitoneal injection of sterile distilled water (1 mL/kg) three times a week for two months 
and oral administration of distilled water (5 mL/kg) for two months. Group 2 (positive control) received 
intraperitoneal injection of TAA (200 mg/kg) three times a week for two months and oral administration 
of distilled water (5 mL/kg) for two months. Group 3 (standard drug control) received intraperitoneal 
injection of TAA (200 mg/kg) three times a week for two months and oral administration of Silymarin  
(50 mg/kg) for two months. Group 4 (low dose ethanol extract treated group) received intraperitoneal 
injection of TAA (200 mg/kg) three times a week for two months and oral administration of I. aquatica 
(250 mg/kg) for two months. Group 5 (high dose ethanol extract treated group) received intraperitoneal 
injection of TAA (200 mg/kg) three times a week for two months and oral administration of I. aquatica 
(500 mg/kg) for two months. 
3.8. Assessment of Liver Function 
Biochemical parameters were analyzed by a standard biochemistry automated analyzer at the Central 
Diagnostic Laboratory of the Medical Centre of University Malaya. Collected blood samples from the rats 
were centrifuged at 3,000 rpm for 10 min. Then the separated serum samples were used to analyze liver 
biochemical parameters, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), 
alkaline phosphatase (AP), total protein, bilirubin and albumin.  
The liver samplez were rinsed with saline and then homogenized (10% w/v) in 50 mM cold potassium 
phosphate buffer (pH 7.4), and thereafter centrifuged at 3,500 rpm for 10 min at 4 °C. Then the 
supernatant was separated and saved for malondialdehyde level (MDA) analysis as per the thiobarbituric 
acid procedure [29,30], which is an indicator for lipid peroxidation levels. Superoxide dismutase (SOD) 
and catalase (CAT) were analyzed by Cayman’s SOD and catalase assay kits. 
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3.9. Histopathological Examination 
Liver histopathological examinations were carried out by means of a light microscope. Liver was fixed 
in 10% buffered formaldehyde, and thereafter processed by programmed tissue processing machine and 
after that embedded in paraffin wax. Following embedding a 5 μm thick section was prepared and stained 
with hematoxylin-eosin (HE) and Masson-Trichrome (MT) for photomicroscopic assessment [31].  
3.10. Statistical Analysis 
All of the values are reported as mean ± S.E.M. The statistical significance of variations between 
groups was analyzed employing one-way ANOVA pursued by Tukey Post-Hoc test analysis using SPSS 
version 18 (SPSS Inc. Chicago, IL, USA) with a value of p < 0.05 was regarded significant when 
compared to the control group. 
4. Conclusions  
In conclusion, the results of this study demonstrate that the I. aquatica was effective in prevention of 
TAA-induced hepatic damage in rats. Our results show that the protective effect of I. aquatica in  
TAA-induced liver damage might contribute to its modulation on detoxification enzymes and its 
antioxidant and free radical scavenger effects. Moreover, it confirms use of I. aquatica traditionally for the 
treatment of liver disorders. 
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